1-3 of 3
Ka Wah Chan, MBBS
Close
Sort by
Journal Articles

Reduced Intensity Conditioning (RIC) Regimen of Alemtuzmab (A), Fludarabine (F), and Melphalan (M) for Transplantation of Pediatric Non-Malignant Hematologic Disorders (NMHD): Outcome Affected by Stem Cell Source.

Ka Wah Chan, MBBS, Michael Grimley, MD, Veronica H. Jude, MD, Lisa McDonald, MSN, Julie Luke, MSN, Dennise Lim, BA, Shalini Shenoy, MD
Journal: Blood
Blood (2010) 116 (21): 3490.
https://doi.org/10.1182/blood.V116.21.3490.3490
Published: 2010
Journal Articles

Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.

Franco Locatelli, MD, PhD, Adrienne Moreno-Madureira, MD, Pierre Teira, MD, Mary Eapen, MBBS, Mei-Jie Zhang, PhD, Stella M. Davies, MBBS, PhD, Alessandra Picardi, MD, Ann E Woolfrey, MD, Ka Wah Chan, MBBS, Gerard Socie, MD, Ajay J. Vora, Yves Bertrand, Joanne Kurtzberg, MD, Carmen Bonfim, MD, Eliane Gluckman, MD, Charlotte M Niemeyer, MD, PhD, Vanderson Rocha, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1964.
https://doi.org/10.1182/blood.V112.11.1964.1964
Published: 2008
Journal Articles

Clinical and Cost Outcomes of Double Umbilical Cord Blood Versus Bone Marrow and Peripheral Blood Unrelated Hematopoietic Stem Cell Transplants.

Guillermo López-González, Charles F. LeMaistre, MD, Carlos Bachier, MD, Brad Smith, PhD, Ka Wah Chan, MBBS, Michael Grimley, MD, Wilma Cain, Elina Delgado, Shawn Kaleel, Paul Shaughnessy, MD
Journal: Blood
Blood (2008) 112 (11): 967.
https://doi.org/10.1182/blood.V112.11.967.967
Published: 2008